Approved Study Database

Ref. No. Scientific Title Principal investigator
2011.171 Oral motor skills in children with speech sound disorders of unknwn origin: a comparison with children normal speech Prof Lee Kathy
2004.058 Oral Health Survey in Psychiatric Patients in Hong Kong UNGVARI Gabor S
2010.368 Oral feeding performance in infants NG Sze Ka
2013.482 Oral Arsenic trioxide in Management of Newly Diagnosed and Relapsed or refractory Acute Promyelocytic Leukemia (PML/RARα) in Children Dr. LI Chi Kong
2014.053 Oral 5-aminosalicyclic Acid Withdrawal in Long Standing Inactive Ulcerative Colitis: A Double-blind, Randomized, Placebo-controlled Trial Prof. NG Siew Chien
2017.001 Optimizing varices screening in cirrhotic patients with well-controlled chronic viral hepatitis: A prospective cohort study with transient elastography and multiparametric magnetic resonance imaging Dr. WONG Vincent Wai Sun
黃煒燊
2021.238 Optimizing Predictions of Dyslexia Cross-Culturally: Chinese and English Compared Prof. MCBRIDE Catherine
2020.601 Optimization of Urine Processing for Biomarker Development of Kidney Diseases Prof. SZETO Cheuk Chun
司徒卓俊
2022.159 Optimization of Peritoneal Dialysis Prescription by Early Determination of Peritoneal Transport Characteristics Prof. SZETO Cheuk Chun
司徒卓俊
2014.270 Optimization of culture method for human adipose derived-msenchymal stem cells with minimal amount of fetal bovine serum Prof. POON Wai Sang
2018.132 Optimization of antibiotics treatment duration in bloodstream infections with a serum procalcitonin-based algorithm Dr. LI Timothy Chun Man
李俊文
2009.217 Optimise CRT Professor Yu Cheuk-Man
2005.121 Optimisation of Antihypertensive Therapies: Application of Pharmacogenomic and Biochemical Technologies ptimisation of Antihypertensive Therapies: Application of Pharmacogenomic and Biochemical Technologies Prof. Brian Tomlinson
2004.302 Optimal Ventricular Resynchronization and Nt-proBNP in Heart Failure Therapy Prof. Yu Cheuk Man
2017.240 Optimal timing of umbilical cord clamping for term babies with natural birth – a randomised open-labelled trial Prof. TAM Wing Hung
譚永雄
2005.442 Optimal Time of Laparoscopic Cholecystectomy After Endoscopic Clearance of Endoscopic Bile Duct Stone Removal in Acute Cholangitis Prof. NG Kwok Wai
2020.224 Optimal Strategy for the Monitoring of Dialysis Adequacy in Peritoneal Dialysis Patients Prof. SZETO Cheuk Chun
司徒卓俊
2019.245 Optimal proximal interphalangeal joint position for treatment of mallet finger: a cadaveric biomechanical study Dr. MAK Suk Ying
麥淑楹
2024.134 Optimal Dosage of Atropine and Red Light Combination Therapy for Myopia Treatment (LAMP-4) Study Dr. YAM Jason Cheuk Sing
2015.291 Optimal Bioabsorbable Vascular Scaffold Technique for Complex Bifurcation Lesions Dr. YAN Bryan Ping Yen
甄秉言
2015.297 Optical Coherence Tomography evaluation of Very Early eNdothelialization after Dual Therapy Drug-eluting Stent with EPC CaptURE (OCT-VENTURE) Prof. YAN Bryan Ping Yen
甄秉言
2017.358 Optical Coherence Tomography evaluation of Bioabsorbable Vascular Scaffold Technique with Magmaris Prof. YAN Bryan Ping Yen
2021.273 Optical Coherence Tomography and Optical Coherence Tomography Angiography features in Cytomegalovirus Retinitis Dr. WONG Po Yin
2021.505 Optical coherence tomography (OCT) for lung imaging Dr. YUAN Wu
袁武
2004.081 Optical Brian Imaging of Incidental and Intentional Memory Retrieval PENNEY Trevor
2015.718 Opt-out HIV testing in out-patient setting Prof. TAM Greta Chun Huen
2019.618 Opioid analgesics during and following radiotherapy treatment of head and neck tumours Dr. CHAN Jason Ying Kuen
2021.135 Operative Mortality After Triple Valve Surgery: Prognostic Value of Simplified MELD-Na Dr. LIM Kevin
2004.314 Open, Randomized, Controlled, Multicenter Phase III Study Comparing 5-FU/FA Plus Irinotecan Plus Cetuximab Versus 5-FU/FA Plus Irinotecan as First-Line Treatment for Epidermal Growth Factor Receptor Prof. Chan Tak Cheung Anthony
2015.087 Open-label, uncontrolled Phase II trial of intravenous PI3K inhibitor BAY 80-6946 in patients with relapsed, indolent or aggressive Non-Hodgkin’s lymphomas (Part B) Dr. WONG Raymond Siu Ming
2016.688 Open-Label, Single Arm, Phase 3b, Multi-Center Study Evaluating the Impact of Venetoclax on the Quality of Life of Relapsed/Refractory Subjects with Chronic Lymphocytic Leukemia (CLL) Including Those with the 17p Deletion or TP53 Mutation OR Those Who Have Received Prior Treatment with a B-Cell Receptor Inhibitor Dr. WONG Raymond Siu Ming
王紹明醫生
2016.597 Open-Label, Randomized Trial of Nivolumab (BMS-936558) plus Pemetrexed/Platinum or Nivolumab plus Ipilimumab (BMS-734016) vs Pemetrexed plus Platinum in Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) Subjects with Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor Therapy Prof. MOK Tony Shu Kam
莫樹錦教授
2006.368 Open-Label Study of Bevacizumab (Avastin_) Plus Taxane Monotherapy or in Combination for the First-Line Treatment of Patients with Locally Recurrent or Metastatic Breast Cancer ATHENA (Avastin THErapy for advaNced bresAst cancer) Dr. Ho Wing Ming
2017.257 Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH) Prof. WONG Vincent Wai Sun
黃煒燊
2008.366 Open-Label Extension Study of 23 mg Donepezil SR in Patients with Moderate to Severe Alzheimer Prof. Mok C.T. Vincent
2008.037 Open Liver Resection with or without Vascular Inflow Occlusion: A Randomised Control Trial Dr Lee Kit-fai
2012.351 Open liver resection with or without vascular inflow occlusion for hepatocellular carcinoma: a randomized controlled trial Dr Lee Kit-fai
2002.500 Open Label Treatment Compassionate Access Programme to Provide Adefovir Dipivoxil and Lamivudine to Patients with Chronic Hepatitis B Infection who are Participating in or Have Completed, As Appropriate, one of the Following GlaxoSmithKline or Gilead Sciences Inc. Clinical Trial : NUC20917, NUC20912, NUC4006, NUC40021 and Study 435 Prof. Sung Jao Yiu Joseph
2006.307 Open Label Study of bevacizumab (AVASTIN_) in Combination with Platinum Containing Chemotherapy as First Line Treatment of Patients with Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer (SAIL-Safety of Avastin In Lung) Prof. Mok Tony
2017.169 Open label single arm study for NEPA [oral fixed-dose combination of 300 mg netupitant and 0.50 mg palonosetron] in Hong Kong oncology patients receiving (neo)-adjuvant chemotherapy treatment consists of adriamycin and cyclophosphamide for breast cancer. Prof. YEO Winnie
2003.259 Open Label Single Arm Phase 2 Study of ALIMTA in Patients with Advanced Non-Small Cell Lung Cancer Who have Prior Chemotherapy Prof. Mok Tony
2005.445 Open Label Extension Study Evaluating the Long Term Safety, Tolerability and Efficacy of An Iron Maintenance Dosing Strategy Utilizing Intravenous VIT-45 in the Treatment of Anemia in Non-Dialysis Dependent (NDD) Chronic Kidney Disease (CKD) Prof. Szeto Cheuk Chun
2002.444 Open Label Extension and Long Term Safety Study of Tolterodine PR Capsules in Children 5 to 11 Years of Age with Symptoms of Urge Urinary Incontinence Suggestive of Detrusor Instability Prof. Yeung Chung Kwong
2015.053 Open globe injuries in geriatric nursing home residents Dr. FONG Yoly Yeuk Ying
2024.089 Open and closed platform robotic-assisted versus conventional total knee arthroplasty: a randomised controlled trial Prof. ONG Michael Tim Yun
2006.270 ONTARGET and TRANSCEND Study (Protocol No. 502.373) CHAN Chi Kin Hamish
2022.188 Online Temporal Processing Assessment and Training for Children Prof. CHAN Agnes Sui Yin
陳瑞燕
2020.486 Online multicomponent health intervention to support children with special education needs (SEN) and their families during COVID-19 pandemic Dr. LEE Eric
李錦培
2014.032 Online Modulation of Auditory Brainstem Responses to Speech Prof. WONG Patrick Chun Man
2022.183 Online Mindfulness-based Intervention to Enhance Bracing Compliance for Adolescent Idiopathic Scoliosis (AIS) – A Pilot Randomized Single-blinded Controlled Trial Prof. LAM Tsz Ping
林子平

Page 83 of 254.